Combined hormonal contraception (other routes): Standard strength preparations (containing ethinylestradiol 30-35 micrograms)
Drug Safety Update
April 2008: Hormonal contraceptives: cervical cancer
April 2008: Combined oral contraceptives show they can prevent ovarian cancer
June 2011: Drospirenone-containing pills risk of venous thromboembolism higher than levonorgestrel-containing pills
February 2014: Combined hormonal contraceptives and venous thromboembolism: review confirms risk is small
March 2014: Combined hormonal contraceptives: risk of venous thromboembolism
March 2014: St John’s wort: interaction with hormonal contraceptives, including implants
Drugs in this section to be initiated in community or by sexual health provider clinics only
Identical to Marvelon®
| Pack |
|---|
| 63 tablet (3 x 21 tablets) |
| Pack |
|---|
| 63 tablet (3 x 21 tablets) |
| Pack |
|---|
| 84 tablet (3 x (21 tablets + 7 tablets)) |
Identical to Femodene®
| Pack |
|---|
| 63 tablet (3 x 21 tablets) |
- On Formulary Preferred
- On Formulary Second Line
- On Formulary Third Line
- Specialist Initiation
- Secondary Care Only
- Not Approved for Formulary